1. Home
  2. MLYS vs FWRG Comparison

MLYS vs FWRG Comparison

Compare MLYS & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • FWRG
  • Stock Information
  • Founded
  • MLYS 2019
  • FWRG 1983
  • Country
  • MLYS United States
  • FWRG United States
  • Employees
  • MLYS N/A
  • FWRG N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • FWRG Restaurants
  • Sector
  • MLYS Health Care
  • FWRG Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • FWRG Nasdaq
  • Market Cap
  • MLYS 893.0M
  • FWRG 1.0B
  • IPO Year
  • MLYS 2023
  • FWRG 2021
  • Fundamental
  • Price
  • MLYS $13.35
  • FWRG $19.59
  • Analyst Decision
  • MLYS Strong Buy
  • FWRG Strong Buy
  • Analyst Count
  • MLYS 3
  • FWRG 10
  • Target Price
  • MLYS $33.00
  • FWRG $22.80
  • AVG Volume (30 Days)
  • MLYS 1.3M
  • FWRG 731.4K
  • Earning Date
  • MLYS 05-08-2025
  • FWRG 05-06-2025
  • Dividend Yield
  • MLYS N/A
  • FWRG N/A
  • EPS Growth
  • MLYS N/A
  • FWRG N/A
  • EPS
  • MLYS N/A
  • FWRG 0.30
  • Revenue
  • MLYS N/A
  • FWRG $1,015,910,000.00
  • Revenue This Year
  • MLYS N/A
  • FWRG $21.47
  • Revenue Next Year
  • MLYS N/A
  • FWRG $15.96
  • P/E Ratio
  • MLYS N/A
  • FWRG $65.30
  • Revenue Growth
  • MLYS N/A
  • FWRG 13.95
  • 52 Week Low
  • MLYS $8.24
  • FWRG $12.90
  • 52 Week High
  • MLYS $18.38
  • FWRG $25.98
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 49.65
  • FWRG 61.63
  • Support Level
  • MLYS $10.44
  • FWRG $15.03
  • Resistance Level
  • MLYS $14.83
  • FWRG $17.31
  • Average True Range (ATR)
  • MLYS 1.49
  • FWRG 1.23
  • MACD
  • MLYS -0.14
  • FWRG 0.37
  • Stochastic Oscillator
  • MLYS 43.24
  • FWRG 94.80

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About FWRG First Watch Restaurant Group Inc.

First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.

Share on Social Networks: